Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 5,495 | 11,565 | 15,604 | 7,876 | 12,001 |
| Cost of Goods | 12,293 | 10,815 | 5,015 | 7,356 | 13,228 |
| Gross Profit | -6,798 | 750 | 10,590 | 520 | -1,228 |
| Operating Expenses | 1,171 | 1,076 | 315 | 654 | 385 |
| Operating Income | -7,676 | 489 | 10,290 | 222 | -1,384 |
| Other Income | -151 | 126 | -34 | -52 | -28 |
| Pre-tax Income | -7,827 | 615 | 10,256 | 170 | -1,412 |
| Income Tax | -1 | 1 | 1 | N/A | N/A |
| Net Income Continuous | -7,826 | 614 | 10,255 | 170 | -1,430 |
| Net Income | $-7,826 | $614 | $10,255 | $170 | $-1,430 |
| EPS Basic Total Ops | -0.15 | 0.01 | 0.20 | 0.00 | -0.03 |
| EPS Basic Continuous Ops | -0.15 | 0.01 | 0.20 | 0.00 | -0.03 |
| EPS Diluted Total Ops | -0.14 | 0.01 | 0.19 | 0.00 | -0.03 |
| EPS Diluted Continuous Ops | -0.15 | 0.01 | 0.19 | 0.00 | -0.03 |
| EBITDA(a) | $-4,118 | $561 | $10,353 | $276 | $-1,327 |